Skip to main navigation Skip to search Skip to main content

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients with Cirrhosis and Hepatorenal Syndrome Type 1

  • Thomas D. Boyer
  • , Arun J. Sanyal
  • , Florence Wong
  • , R. Todd Frederick
  • , John R. Lake
  • , Jacqueline G. O'Leary
  • , Daniel Ganger
  • , Khurram Jamil
  • , Stephen Chris Pappas
  • , Samuel H. Sigal
  • , Santiago J. Munoz
  • , Vishal Patel
  • , Paul Y. Kwo
  • , Jasmohan S. Bajaj
  • , Tarek I. Hassanein
  • , Kirti Shetty
  • , Rohit Satoskar
  • , K. Rajender Reddy
  • , Marlyn Mayo
  • , Victor Araya
    • Nikroo Hashemi, Eyob Feyssa, Lorenzo Rossaro, David Kravetz, Priya Grewal, Ram Subramanian, Kevin Korenblat, Yuri Stepanovich Genyk, Fredric Regenstein, Joseph F. Buell, Nathan J. Shores, Sukru H. Emre, Andrea Duchini, Atif Zaman, Marco Antonio Olivera-Martinez, Michael K. Porayko, Alex S. Befeler, K. Gautham Reddy, Maria Del Pilar Hernandez, Stephen D. Zucker, Hugo E. Vargas, Michael Curry, Adnan Said, Kris V. Kowdley, Terry Box, David Shields Barnes, Marie Noëlle Pépin, Madhavi Rudraraju, Paul Angulo, Howard P. Monsour, David Wolf, Charles Howell, Fredric G. Regenstein, Antonio Sanchez, Hany Elbeshbeshy, Michael B. Fallon, Colin Swales, David A. Sass, Eva Urtasun Sotil, Brendan McGuire, Richard K. Gilroy, Juan A. Guerrero, Mark N. Wong, Obaid Shaikh, Stevan Gonzalez, Zeid Kayali

Research output: Contribution to journal › Article › peer-review

285   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients with Cirrhosis and Hepatorenal Syndrome Type 1'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science